A difficult trade off for adults with membranous nephropathy

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f248 (Published 16 January 2013)
Cite this as: BMJ 2013;346:f248

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Immunosuppression is an established but controversial treatment for patients with idiopathic membranous nephropathy. Supporting evidence is patchy, particularly for the minority of patients with worsening renal function. A new trial reports that the combination of chlorambucil and prednisolone does slow …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL